Loading...
•
Sep 30, 2021
Pediatrix Q3 2021 Earnings Report
Mednax reported Q3 2021 earnings with revenue increase and strategic investments.
Key Takeaways
Mednax reported a net revenue of $493 million and income from continuing operations of $32 million, or $0.37 per share, for the third quarter of 2021. Adjusted EPS from continuing operations was $0.46. The company also invested in Brave Care to accelerate activities in pediatric primary and urgent care.
Net revenue reached $493 million.
Income from continuing operations was $32 million.
Adjusted EPS from continuing operations was $0.46.
Invested in Brave Care to enhance pediatric care activities.
Forward Guidance
No forward guidance was provided in the earnings report.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...